Large-scale field application of RNAi technology reducing Israeli acute paralysis virus disease in honey bees (Apis mellifera, Hymenoptera: Apidae).

PLoS Pathog · 2010 · PMC3009593 · PMID 21203478

Europe PMC DOI

hedged sentence

0.0005

closest p · 0.0× alpha

0.0005

boldest claim

The sentences

highly significantP = 0.0005actually significant

Nosema levels: While the change in nosema levels in the FL trial was not significantly different between treatment groups (F 4,95 = 0.47; P = 0.7586), a highly significant difference in nosema spore levels was detected at the end of the PA trial (F 2,57 = 8.62; P = 0.0005) ( Figure 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.